Open access
Open access
Powered by Google Translator Translator

Psychiatry

RCT | Transcranial direct current stimulation fails to outperform sham in major depressive disorder treatment

5 Jul, 2023 | 01:12h | UTC

Transcranial direct current stimulation as an additional treatment to selective serotonin reuptake inhibitors in adults with major depressive disorder in Germany (DepressionDC): a triple-blind, randomised, sham-controlled, multicentre trial – The Lancet (link to abstract – $ for full-text)

 


USPSTF Recommendations | Screen for anxiety disorders in adults, including pregnant and postpartum women

30 Jun, 2023 | 15:03h | UTC

Screening for Anxiety Disorders in Adults: US Preventive Services Task Force Recommendation Statement – JAMA

Editorial: Are There Reasons to Fear Anxiety Screening? – JAMA

Evidence Report: Anxiety Screening: Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Patient Page: Screening for Anxiety Disorders in Adults – JAMA

Author Interview: USPSTF Recommendations: Screening for Depression and Suicide Risk in Adults, and Screening for Anxiety Disorders in Adults – JAMA

Commentary: U.S. Preventive Services Task Force Recommends Screening Adults for Anxiety Disorders – Psychiatric News Alert

 


M-A | Comparing the efficacy of different types of exercise for the treatment and prevention of depression in youths

30 Jun, 2023 | 14:40h | UTC

Comparing the efficacy of different types of exercise for the treatment and prevention of depression in youths: a systematic review and network meta-analysis – Frontiers in Psychiatry

 


Consensus Paper | Care for older forensic mental health patients

29 Jun, 2023 | 13:54h | UTC

Care for older forensic mental health patients: A consensus guidance document – European Psychiatry

 


Perspective | Psychedelic treatments for mental health conditions pose challenges for informed consent

28 Jun, 2023 | 13:17h | UTC

Psychedelic treatments for mental health conditions pose challenges for informed consent – Nature Medicine

 


M-A | Lifetime burden of psychological symptoms, disorders, and suicide due to cancer in childhood, adolescent, and young adult years

26 Jun, 2023 | 00:39h | UTC

Lifetime Burden of Psychological Symptoms, Disorders, and Suicide Due to Cancer in Childhood, Adolescent, and Young Adult Years: A Systematic Review and Meta-analysis – JAMA Pediatrics (free for a limited period)

Editorial: Poor Mental Health Among Survivors of Childhood Cancer—Risk Factors and a Call for Intervention – JAMA Pediatrics (free for a limited period)

 


Cohort Study | Real-world data links valproate, antipsychotics to higher diabetes risk in bipolar disorder

23 Jun, 2023 | 13:32h | UTC

Pharmacological treatment of bipolar disorder and risk of diabetes mellitus: A nationwide study of 30,451 patients – Bipolar Disorders

 


RCT | Dexmedetomidine administration shows promise in PTSD reduction for trauma surgery patients

23 Jun, 2023 | 13:30h | UTC

Effect of Dexmedetomidine on Posttraumatic Stress Disorder in Patients Undergoing Emergency Trauma Surgery: A Randomized Clinical Trial – JAMA Network Open

See also: Visual Abstract

 


Cohort Study | Increased depression risk observed in first two years of oral contraceptive use

23 Jun, 2023 | 13:19h | UTC

Population-based cohort study of oral contraceptive use and risk of depression – Epidemiology and Psychiatric Sciences

News Release: New study links contraceptive pills and depression – Uppsala University

Commentary: Depression Risk May Rise During First Two Years of Oral Contraceptive Use – Psychiatric News Alert

 

Commentary on Twitter

 


Evidence Analysis | ADHD: evidence to help you decide how best to manage the condition

19 Jun, 2023 | 13:45h | UTC

ADHD: evidence to help you decide how best to manage the condition – Evidently Cochrane

 


Cohort Study | Alcohol consumption and risks of more than 200 diseases in Chinese men

16 Jun, 2023 | 13:55h | UTC

Alcohol consumption and risks of more than 200 diseases in Chinese men – Nature Medicine

News Release: Alcohol consumption increases the risks of over 60 diseases – University of Oxford

 


Evidence-based clinical practice guideline for deprescribing opioid analgesics

15 Jun, 2023 | 15:08h | UTC

Evidence-based clinical practice guideline for deprescribing opioid analgesics – University of Sidney

 


M-A | Influencing factors of medication adherence in schizophrenic patients

15 Jun, 2023 | 14:56h | UTC

Influencing factors of medication adherence in schizophrenic patients: a meta-analysis – Schizophrenia

 


Review | Candidate biomarkers in psychiatric disorders

15 Jun, 2023 | 14:52h | UTC

Candidate biomarkers in psychiatric disorders: state of the field – World Psychiatry

 


Crossover RCT | THC and Cannabidiol demonstrate potential in Tourette syndrome tic management, despite cognitive impacts

14 Jun, 2023 | 14:27h | UTC

Tetrahydrocannabinol and Cannabidiol in Tourette Syndrome – NEJM Evidence

 


Review | Diagnosis and management of depression in adolescents

13 Jun, 2023 | 14:05h | UTC

Diagnosis and management of depression in adolescents – Canadian Medical Association Journal

News Release: How to diagnose and manage depression in adolescents: A new review for clinicians – Canadian Medical Association Journal

 


Cohort Study | Almost a third of bipolar disorder patients non-adherent to 20% or more of prescriptions

12 Jun, 2023 | 13:29h | UTC

Non-adherence to mood stabilizers and antipsychotics among persons with bipolar disorder – A nationwide cohort study – Journal of Affective Disorders

 


Cohort Study | Cannabis use disorder linked to increased risk of depression and bipolar disorder

5 Jun, 2023 | 13:26h | UTC

Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar Disorder – JAMA Psychiatry (link to abstract – $ for full-text)

Author Interview: Cannabis Use Disorder and Subsequent Risk of Unipolar Depression and Bipolar Disorder

Commentary: Expert reaction to study of cannabis use disorder, bipolar disorder, and depression – Science Media Centre

 


Systematic Review | Bupropion and nortriptyline: an assessment of their effectiveness in smoking cessation

2 Jun, 2023 | 12:28h | UTC

Antidepressants for smoking cessation – Cochrane Library

 


Position Statement | Athletes with attention-deficit/hyperactivity disorder

2 Jun, 2023 | 12:24h | UTC

Athletes With Attention-Deficit/Hyperactivity Disorder: Position Statement of the American Medical Society for Sports Medicine – Clinical Journal of Sport Medicine

 


Review | Medication-assisted recovery for opioid use disorder

2 Jun, 2023 | 12:03h | UTC

Medication-assisted recovery for opioid use disorder: A guide – Journal of Family Practice

 


SR | Individual‐level interventions for reducing occupational stress in healthcare workers

1 Jun, 2023 | 12:18h | UTC

Individual‐level interventions for reducing occupational stress in healthcare workers – Cochrane Library

News Release: Stress-management interventions may help individual healthcare workers for at least a year – Cochrane Library

 


M-A | Maternal alcohol consumption and the risk of miscarriage in the first and second trimesters

1 Jun, 2023 | 12:10h | UTC

Maternal alcohol consumption and the risk of miscarriage in the first and second trimesters: a systematic review and dose–response meta-analysis – Acta Obstetricia et Gynecologica Scandinavica

 


RCT | Adapted mindfulness training shows efficacy in reducing elevated office blood pressure

1 Jun, 2023 | 12:03h | UTC

Effect of Adapted Mindfulness Training in Participants With Elevated Office Blood Pressure: The MB‐BP Study: A Randomized Clinical Trial – Journal of the American Heart Association

 


RCT | Ketamine non-Inferiority to ECT for nonpsychotic resistant depression

31 May, 2023 | 14:15h | UTC

Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression – New England Journal of Medicine (link to abstract – $ for full-text)

News Release: Study Finds Ketamine is at Least as Effective as ECT for Treating Major Depression – Mass General Brigham

Commentary: Expert reaction to trial looking at ketamine versus ECT for nonpsychotic treatment-resistant major depression – Science Media Centre

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.